[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368696-105":59,"doc-detail-368696-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","neuroendocrine-neoplasms-in-pregnancy-a-narrative-review-clinical-challenges-and-therapeutic-limitations","Neuroendocrine Neoplasms in Pregnancy: A Narrative Review - Clinical Challenges and Therapeutic Limitations","","Neuroendocrine neoplasms (NENs) during pregnancy are rare yet clinically demanding due to hormonal activity, histologic diversity, and limited gestational management data. Cancer in pregnancy is uncommon (~0.1%) but linked to higher maternal morbidity, and delayed childbearing may increase incidence. This narrative review synthesizes evidence on diagnosis, staging, and treatment, emphasizing maternal–fetal safety, diagnostic constraints, unreliable biomarkers, contraindications to standard therapies, and the need for individualized multidisciplinary planning.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/neuroendocrine-neoplasms-in-pregnancy-a-narrative-review-clinical-challenges-and-therapeutic-limitations/368696/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/neuroendocrine-neoplasms-in-pregnancy-a-narrative-review-clinical-challenges-and-therapeutic-limitations/368696.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are neuroendocrine neoplasms particularly challenging during pregnancy?","Question",{"text":112,"@type":113},"NENs have hormonal activity and histologic diversity, and management is constrained by limited pregnancy-specific evidence, affecting diagnosis, staging, and treatment planning.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What complicates diagnosis and treatment of NENs during pregnancy?",{"text":117,"@type":113},"Pregnancy can mimic malignancy-related symptoms, standard imaging and systemic therapies may be contraindicated, and biomarkers such as chromogranin A and 5-HIAA may be unreliable.",{"name":119,"@type":110,"acceptedAnswer":120},"How should treatment decisions regarding pregnancy continuation or termination be made?",{"text":121,"@type":113},"They must be individualized and supported by a multidisciplinary team, coordinating oncology, maternal–fetal medicine, and supportive care to balance maternal and fetal risks.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368696,1790465780,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nNeuroendocrine Neoplasms in Pregnancy: A Narrative Review of Clinical Challenges and Therapeutic Limitations in the Absence of Established Safe Treatments  \nMauro Daniel Spina Donadio 1,*, Maria Cecília Mathias-Machado 2, Danielly Scaranello Nunes Santana 3 and Renata D’Alpino Peixoto 4  \nReceived: 13 May 2025  \nRevised: 17 June 2025  \nAccepted: 23 June 2025  \nPublished: 25 June 2025  \nCitation: Donadio, M.D.S.; Mathias-Machado, M.C.; Santana, D.S.N.; Peixoto, R.D. Neuroendocrine Neoplasms in Pregnancy: A Narrative Review of Clinical Challenges and Therapeutic Limitations in the Absence of Established Safe Treatments.  \nJ. Pers. Med. 2025, 15, 272. [https://](https://)[ ](https://)[doi.org/10.3390/jpm15070272](doi.org/10.3390/jpm15070272)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/lice](https://creativecommons.org/lice)[nses/by/4.0/](nses/by/4.0/)) .  \n1 Oncoclínicas, São Paulo 04538-132, SP, Brazil  \n2 Oncoclínicas, Salvador 40050-410, BH, Brazil; [cissa.mathias@gmail.com](cissa.mathias@gmail.com)  \n3 GineCare, Jundiaí 13208-703, SP, Brazil; [dany.fmj@terra.com.br](dany.fmj@terra.com.br)  \n4 Medical Oncology Department, BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada; [renatadalpino@gmail.com](renatadalpino@gmail.com)  \n* [Correspondence: mauro.donadio@medicos.oncoclinicas.com](Correspondence: mauro.donadio@medicos.oncoclinicas.com)  \nAbstract  \nCancer during pregnancy is a rare but complex clinical scenario that affects approximately 0.1% of pregnant individuals and is associated with increased maternal morbidity. With the trend of delayed childbearing, the incidence of pregnancy-associated cancers is expected to rise. Neuroendocrine neoplasms (NENs), although rare in pregnancy, present unique diagnostic and therapeutic challenges due to their hormonal activity, histological diversity, and limited data on management in the gestational context. Objectives: This manuscript reviews the current evidence on the diagnosis, staging, and management of NENs during pregnancy, focusing on maternal–fetal safety, therapeutic limitations, and multidisciplinary care strategies. Methods: A comprehensive narrative review was conducted using relevant case reports, retrospective studies, clinical guidelines, and expert consensus documents addressing cancer in pregnancy and NEN-specific management. Results: Pregnancy complicates the evaluation and treatment of NENs due to overlapping symptoms, contraindications to standard imaging and systemic therapies, and unreliable biomarkers such as chromogranin A and 5-HIAA. Most systemic therapies for NENs, including somatostatin analogs, tyrosine kinase inhibitors, and peptide receptor radionuclide therapy, are contraindicated or lack safety data in pregnancy. Surgical interventions and supportive care require careful planning. Decisions regarding pregnancy continuation or termination must be individualized and supported by a multidisciplinary team. Conclusions: The management of NENs during pregnancy demands a highly individualized approach, coordinated among oncology, maternal–fetal medicine, and supportive care teams. Given the paucity of robust data, future research is essential to establish evidence-based guidelines and improve outcomes for both mother and fetus.  \nKeywords: neuroendocrine neoplasia; pregnancy; maternal–fetal medicine  \n1. The Impact of Cancer Concurrent with Pregnancy  \nCancer is the second leading cause of death among reproductive-age women, affecting approximately 0.1% of pregnant individuals [1,2] . Although rare, its clinical impact is significant due to the need to balance maternal and fetal health, posing challenges in diagnosis and treatment, as well as the risk of adverse events such as intensive care unit  \n(ICU) admission, bleeding, preterm birth, low birth we","cbCaiaGb7fRwm8pm","https://ap.wps.com/l/cbCaiaGb7fRwm8pm","pdf",273103,16,"English","# Abstract\n# 1. The Impact of Cancer Concurrent with Pregnancy\n## Epidemiology and rising incidence\n## Diagnostic and treatment challenges\n## Outcomes and confounding factors\n## Rare transplacental transmission\n# 2. Neuroendocrine Neoplasms: Biological Diversity and Clinical Implications","[{\"question\":\"Why are neuroendocrine neoplasms particularly challenging during pregnancy?\",\"answer\":\"NENs have hormonal activity and histologic diversity, and management is constrained by limited pregnancy-specific evidence, affecting diagnosis, staging, and treatment planning.\"},{\"question\":\"What complicates diagnosis and treatment of NENs during pregnancy?\",\"answer\":\"Pregnancy can mimic malignancy-related symptoms, standard imaging and systemic therapies may be contraindicated, and biomarkers such as chromogranin A and 5-HIAA may be unreliable.\"},{\"question\":\"How should treatment decisions regarding pregnancy continuation or termination be made?\",\"answer\":\"They must be individualized and supported by a multidisciplinary team, coordinating oncology, maternal–fetal medicine, and supportive care to balance maternal and fetal risks.\"}]","Neuroendocrine Neoplasms in Pregnancy: A Narrative Review - Clinical Challenges and Therapeutic Limitations | PDF",1790178104,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63662302d9f13b429445dec219489c3a.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc0b84bc3849a204e0215c18c1d57c4a.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/854ee438ade3e129cc321d88afc35ea4.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c73ffc21094e632a2580f72f911cd4d.webp",980,1385]